Cancer and atrial fibrillation: Epidemiology, mechanisms, and anticoagulation treatment

被引：28
作者：
Menichelli, Danilo [1 ]
Vicario, Tommasa [2 ,3 ]
Ameri, Pietro [4 ,6 ]
Toma, Matteo [4 ,6 ]
Violi, Francesco [1 ,5 ]
Pignatelli, Pasquale [1 ,5 ]
Pastori, Daniele [1 ]
机构：
[1] Sapienza Univ Rome, Dept Clin Internal Anesthesiol & Cardiovasc Sci, Rome, Italy
[2] Sapienza Univ Rome, Dept Gen Surg & Surg Specialties Paride Stefanini, Rome, Italy
[3] Policlin Tor Vergata Hosp, Emergency Dept, Rome, Italy
[4] IRCCS Osped Policlin San Martino, Cardiovasc Dis Unit, Genoa, Italy
[5] Mediterranea Cardioctr, Naples, Italy
[6] Univ Genoa, Dept Internal Med, Genoa, Italy
来源：
PROGRESS IN CARDIOVASCULAR DISEASES | 2021年 / 66卷
关键词：
Atrial fibrillation; Cancer; Oral anticoagulants; Chemotherapy; Radiotherapy; DOACs; DIRECT ORAL ANTICOAGULANTS; OXIDATIVE STRESS; RISK-FACTORS; CARDIOVASCULAR TOXICITY; POSITION PAPER; 2016; ESC; WARFARIN; SAFETY; THROMBOCYTOPENIA; THROMBOEMBOLISM;
D O I：
10.1016/j.pcad.2021.04.004
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Cancer patients are at an increased risk of developing atrial fibrillation (AF) and thrombosis. However, the management of anticoagulation in patients with both diseases may be challenging, and data on these patients are lacking. We summarize the current evidence on the incidence and prevalence of cancer in AF and vice versa and provide some practical considerations on the management of oral anticoagulation in specific clinical situations. Low-molecular weight heparins are not approved for thromboprophylaxis in AF, and management of warfarin can be difficult. The use of direct oral anticoagulants may be particularly attractive for their rapid onset/ offset action and lower bleeding risk. (c) 2021 Elsevier Inc. All rights reserved.
引用
收藏
页码：28 / 36
页数：9
相关论文
共 85 条
  • [41] Apixaban and dalteparin in active malignancy-associated venous thromboembolism: The ADAM VTE trial
    McBane, Robert D., II
    Wysokinski, Waldemar E.
    Le-Rademacher, Jennifer G.
    Zemla, Tyler
    Ashrani, Aneel
    Tafur, Alfonso
    Perepu, Usha
    Anderson, Daniel
    Gundabolu, Krishna
    Kuzma, Charles
    Perez Botero, Juliana
    Ferre, Roberto A. Leon
    Henkin, Stanislav
    Lenz, Charles J.
    Houghton, Damon E.
    Vishnu, Prakash
    Loprinzi, Charles L.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 18 (02) : 411 - 421
  • [42] Efficacy and Safety of Apixaban Versus Warfarin in Patients with Atrial Fibrillation and a History of Cancer: Insights from the ARISTOTLE Trial
    Melloni, Chiara
    Dunning, Allison
    Granger, Christopher B.
    Thomas, Laine
    Khouri, Michel G.
    Garcia, David A.
    Hylek, Elaine M.
    Hanna, Michael
    Wallentin, Lars
    Gersh, Bernard J.
    Douglas, Pamela S.
    Alexander, John H.
    Lopes, Renato D.
    [J]. AMERICAN JOURNAL OF MEDICINE, 2017, 130 (12) : 1440 - +
  • [43] CISPLATIN-INDUCED ATRIAL-FIBRILLATION
    MENARD, O
    MARTINET, Y
    LAMY, P
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (01) : 192 - 193
  • [44] Atrial fibrillation in cancer patients: Hindsight, insight and foresight
    Mery, Benoite
    Guichard, Jean-Baptiste
    Guy, Jean-Baptiste
    Vallard, Alexis
    Barthelemy, Jean-Claude
    Da Costa, Antoine
    Magne, Nicolas
    Bertoletti, Laurent
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 240 : 196 - 202
  • [45] Cancer treatment and survivorship statistics, 2019
    Miller, Kimberly D.
    Nogueira, Leticia
    Mariotto, Angela B.
    Rowland, Julia H.
    Yabroff, K. Robin
    Alfano, Catherine M.
    Jemal, Ahmedin
    Kramer, Joan L.
    Siegel, Rebecca L.
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2019, 69 (05) : 363 - 385
  • [46] Cyclooxygenases and the cardiovascular system
    Mitchell, Jane A.
    Kirkby, Nicholas S.
    Ahmetaj-Shala, Blerina
    Armstrong, Paul C.
    Crescente, Marilena
    Ferreira, Plinio
    Pires, Maria Elisa Lopes
    Vaja, Ricky
    Warner, Timothy D.
    [J]. PHARMACOLOGY & THERAPEUTICS, 2021, 217
  • [47] ROS signalling in the biology of cancer
    Moloney, Jennifer N.
    Cotter, Thomas G.
    [J]. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2018, 80 : 50 - 64
  • [48] Predictive value of preoperative tissue Doppler echocardiographic analysis for postoperative atrial fibrillation after pulmonary resection for lung cancer
    Nojiri, Takashi
    Maeda, Hajime
    Takeuchi, Yukiyasu
    Funakoshi, Yasunobu
    Maekura, Ryoji
    Yamamoto, Kazuhiro
    Okumura, Meinoshin
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2010, 140 (04) : 764 - 768
  • [49] Relation Between Cancer and Atrial Fibrillation (from the REasons for Geographic And Racial Differences in Stroke Study)
    O'Neal, Wesley T.
    Lakoski, Susan G.
    Qureshi, Waqas
    Judd, Suzanne E.
    Howard, George
    Howard, Virginia J.
    Cushman, Mary
    Soliman, Elsayed Z.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2015, 115 (08) : 1090 - 1094
  • [50] Risk Factors for Atrial Fibrillation After Lung Cancer Surgery: Analysis of The Society of Thoracic Surgeons General Thoracic Surgery Database
    Onaitis, Mark
    D'Amico, Thomas
    Zhao, Yue
    O'Brien, Sean
    Harpole, David
    [J]. ANNALS OF THORACIC SURGERY, 2010, 90 (02) : 368 - 374
123456789